Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | income compounder · medium |
| Evidence | 7/8 load-bearing inputs sourced — missing: Capex |
| Triangulated fair value | ~$48 (≈ +1% vs spot) — precision reflects LOW valuation confidence |
| 12-mo scenario PWEV | ~$49 (≈ +5% vs spot) |
| Next catalyst | 2026-10-29 — Quarterly earnings |
| Primary thesis-break | Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · income compounder · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $47.03 |
| Triangulated Fair Value | $47.60 (+1% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $49.21 (+5% vs spot · 12m PWEV) |
| Forward P/E | 18.2x |
| Market Cap | $15B |
| 52-Week Range | $35.73–$51.01 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across two weighted anchors — a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-09-08. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 57.3/100 (47th pct) | +5% 1yr expected | Hold | Covered Call | 50d — Quarterly earnings |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $47.60 (+1% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
Omega Healthcare Investors is a healthcare trust that owns skilled nursing and assisted living facilities let to operators on long-term leases. The engine models an operating margin near 70%, which is landlord economics — rent in, interest and depreciation out — and the trust carries net debt of ~$4.4B. At $47.03 on 9 September 2026 the shares are fairly valued against the engine's triangulated fair value (+1%), at roughly 18 times forward earnings, with a distribution yield that is the main reason the shares are owned. The structure hides where the risk actually sits. The rent is contractual, but the operator's ability to pay it is not: skilled nursing revenue is dominated by government reimbursement and the cost line by nursing labour, so the tenant's rent coverage — not the lease document — is the real security. The variable that decides is that coverage. The most damaging risk is a reimbursement change or labour-cost shock that compresses operator margins across the portfolio at once: unlike a diversified landlord's tenant defaults, this failure correlates, and re-tenanting a specialised care facility is slow and expensive.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($47.03) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The bear mechanism is tenant credit, and it is correlated by construction. Every operator in a skilled nursing portfolio draws revenue from the same public payers and hires from the same nursing labour pool, so a reimbursement rate that lags wage inflation compresses operator margins simultaneously across the book. Rent coverage thins, deferrals appear, restructurings follow — and reported rental income lags the deterioration, so the accounts look fine until they do not. Re-tenanting is the trap: a purpose-built care facility has few alternative uses, so a failed operator means downtime, capital to reposition, and rent reset lower rather than a clean replacement. Layer a rate shock on top and asset value falls through capitalisation-rate expansion while refinancing net debt of ~$4.4B raises the cost of holding it, cutting the distribution that supports the share price. With an operating margin near 70% there is no cost line to cut — the landlord's expenses are interest and depreciation. The engine's structural branch prices below the 52-week low.
Key Debate
P/E Multiple explains 94% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 23.8× consensus forward EPS, and a peer median 22.3×.
Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 1.1 | 1.3 | High |
| EPS | 2.0 | 2.6 | Medium |
| Target price | 51.9 | 49.2 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Rate Shock / Oversupply / Secular Decline' downside ($25.02) to a 'Bull — Cap-Rate Compression / Re-Rate' bull case ($76.85); the probability-weighted blend (PWEV $49.21) is +5% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Rate Shock / Oversupply / Secular Decline | 20% | $25.02 | -47% |
| Recession / Occupancy & SS-NOI Decline | 17% | $40.47 | -14% |
| Base — FFO Growth + Stable Cap Rates | 35% | $51.75 | +10% |
| Growth — Same-Store NOI + External Growth | 20% | $65.34 | +39% |
| Bull — Cap-Rate Compression / Re-Rate | 8% | $76.85 | +63% |
| Probability-Weighted (PWEV) | — | $49.21 | +5% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 3.7% of revenue; free cash flow net of SBC is $0.12B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Rate Shock / Oversupply / Secular Decline (20%, $25.02). Structural impairment — rate shock / oversupply / secular decline: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Recession / Occupancy & SS-NOI Decline (17%, $40.47). Cyclical downturn — same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend weakens for 1–2 years before normalising.
- Base — FFO Growth + Stable Cap Rates (35%, $51.75). Mid-cycle — normalised same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend; disciplined capital allocation; steady returns.
- Growth — Same-Store NOI + External Growth (20%, $65.34). Upside — NOI growth + cap-rate compression lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Cap-Rate Compression / Re-Rate (8%, $76.85). Upside tail — sustained tight conditions or a structural re-rate on NOI growth + cap-rate compression.
Valuation Triangulation
Two weighted anchors — a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat two numbers as two independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $44.91 | -5% | 37% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $21.46 | -54% | 0% — cross-check only |
| Scenario PWEV | multiple | $49.21 | +5% | 62% (declared 25%) |
| Triangulated (weighted) | — | $47.60 | +1% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts, peer P/E re-rate are not computed, so 60% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
FFO, P/FFO & Distributions
For a REIT, GAAP EPS is meaningless — depreciation is a massive non-cash charge, so REITs are valued on Funds From Operations (FFO ≈ net income + real-estate D&A) and P/FFO, not P/E. Every 'earnings' and 'multiple' figure in this report is therefore on an FFO basis.
| Metric | Value |
|---|---|
| FFO / share (trailing) | $2.59 |
| P/FFO (current) | 19.1x |
| Dividend yield | 5.4% |
The valuation runs on FFO × P/FFO (the standard REIT frame); the cash-flow DCF is omitted (a REIT's development/maintenance capex is funded against the asset base, not free cash). The dividend yield (5.4%) is the income anchor; cap-rate / interest-rate moves and same-store NOI drive the scenarios.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $44.91 and 43% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (94% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $21.46; the peer-median forward P/E is 22.3x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 62% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| HR | 10.8× | 5% | 12% | segment | 50% |
| SBRA | 32.1× | 5% | 31% | broad | 25% |
| JLL | 15.0× | 6% | 3% | direct | 100% |
| LAMR | 29.5× | 3% | 25% | broad | 25% |
Quality-weighted forward P/E: 17.9× (simple median 22.3×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $35.73–$51.01, centre $42.70 (-9% vs spot); spot sits at the 74th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $47.60 (+1% vs spot · triangulated FV) |
| Downside to bear case (Structural — Rate Shock / Oversupply / Secular Decline) | $25.02 (-47% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the reward leg is negligible: the ratio would round to zero at display precision, not asymmetric enough to print |
| Margin of safety (FV vs spot) | +1% |
| P(price > spot) — Monte Carlo | 43% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; here the modelled upside is under a twentieth of the modelled downside, so the displayed ratio would read as exactly zero and is withheld rather than printed as a figure the document would immediately disown. Bull case (Bull — Cap-Rate Compression / Re-Rate): $76.85.
Company Overview & Business Model
Omega Healthcare Investors Inc — REAL ESTATE · REIT - HEALTHCARE FACILITIES. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily skilled nursing and assisted living facilities.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Real Estate (FFO) | 100% | +5% | 70% | same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend |
Edge. Narrow moat — inferred from a 70% operating margin and the real estate (FFO) business model. Some pricing power / share stability; terminal multiple near the market.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Real Estate (FFO) | $1.2B | 100% | 5% | 70% | $0.8B | 19.0x | 15% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend |
| net_debt_or_cash_b | -4.42 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.15 |
| div_yield | 0.0537 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | rate shock / oversupply / secular decline |
| upside | NOI growth + cap-rate compression |
Industry Context — Real Estate
This name sits in the Real Estate cluster as a real estate (FFO) name. same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: WPC (real estate (FFO)) · LAMR (cyclical REIT (FFO)) · OHI (real estate (FFO)) · JLL (real estate services) · AMH (real estate (FFO)) · ELS (real estate (FFO)) · GLPI (cyclical REIT (FFO)) · EGP (growth REIT (FFO)) · AHR (real estate (FFO)) · CTRE (real estate (FFO)) · BRX (real estate (FFO)) · ADC (real estate (FFO)) · CUBE (growth REIT (FFO)) · FR (growth REIT (FFO)) · NNN (real estate (FFO)) · REXR (growth REIT (FFO)) · VNO (cyclical REIT (FFO)) · STAG (growth REIT (FFO)) · HR (real estate (FFO)) · NSA (real estate (FFO)) · RYN (cyclical REIT (FFO)) · KRG (real estate (FFO)) · CUZ (cyclical REIT (FFO)) · SBRA (real estate (FFO)) · EPR (cyclical REIT (FFO)) · KRC (cyclical REIT (FFO)) · CDP (cyclical REIT (FFO)) · IRT (real estate (FFO)) · PK (cyclical REIT (FFO))
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Rate Shock / Oversupply / Demand Loss | not stated | 37% | 37% |
| Mid-Cycle — FFO Growth + Stable Cap Rates | not stated | 35% | 35% |
| Upside — NOI Growth / Cap-Rate Compression | not stated | 28% | 28% |
Mapping note: name-level 'Structural — Rate Shock / Oversupply / Secular Decline' (20%) + 'Recession / Occupancy & SS-NOI Decline' (17%) map to cluster Rate Shock / Oversupply / Demand Loss (37%); name-level 'Growth — Same-Store NOI + External Growth' (20%) + 'Bull — Cap-Rate Compression / Re-Rate' (8%) map to cluster Upside — NOI Growth / Cap-Rate Compression (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Rate Shock / Oversupply / Demand Loss — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The Real Estate cycle is the shared macro driver. Driver — same-store NOI + occupancy + FFO growth + cap rates / interest rates + property demand. Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $4.2B — highly levered |
| Net debt / EBITDA | 3.71x |
| Interest coverage (EBIT / interest) | 3.8x |
| Current ratio | 3.46x |
| Cash & ST investments | $0.0B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.2B |
| Buybacks / dividends | $0.6B / $0.8B |
| Total shareholder yield | 9.3% |
| Payout as % of FCF | 856.2% |
| Reinvestment (capex / OCF) | 81.6% |
| SBC as % of FCF | 27.2% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 13.5% |
| FCF conversion (FCF / net income) | 26.6% |
| FCF yield | 1.1% |
| Capex intensity (capex / revenue) | 59.8% |
| FCF − SBC (diagnostic) | $0.1B |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 144% — cash-backed.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.32 vs analyst floor +0.00 → delta +0.32 (n=37 mgmt / 36 Q&A; 32nd pctile across the S&P book, z -0.6).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.32 | +0.00 | +0.32 |
| 2025Q4 | +0.43 | +0.26 | +0.17 |
| 2025Q3 | +0.62 | +0.45 | +0.18 |
| 2025Q2 | +0.39 | +0.04 | +0.35 |
News (last 365d, 313 articles): avg ticker sentiment +0.19 (bullish 25% / bearish 3%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $51.94 (+10% vs spot · street) |
| House target | $49.21 (-5.3% vs street) |
| Sell-side coverage | 20 analysts (SB 2 / B 6 / H 10 / S 0 / SS 2; net score 0.15) |
| Consensus FY EPS | $1.98 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $1.1B; house above (+20.1%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-10-29 (~51d) — Quarterly earnings — est. EPS $0.79 (AV EARNINGS_CALENDAR)
Forecast Track Record
- EPS surprise: beat 62% of the last 8 quarters; average surprise +8.6%.
- Prior-forecast backtest (19 snapshots, 2026-07-21→2026-09-03): directional hit-rate 79%; mean predicted +2.4% vs realised -2.1%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
5 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 7d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 9d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 35d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 49d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-10-29 (in 50d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-12-09 (in 91d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 100d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 140d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 189d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 191d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 231d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 273d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 282d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Rate Shock / Oversupply / Secular Decline | Cluster state Rate Shock / Oversupply / Demand Loss — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Recession / Occupancy & SS-NOI Decline | Cluster state Rate Shock / Oversupply / Demand Loss — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Base — FFO Growth + Stable Cap Rates | Cluster state Mid-Cycle — FFO Growth + Stable Cap Rates — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Growth — Same-Store NOI + External Growth | Cluster state Mid-Cycle — FFO Growth + Stable Cap Rates — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Bull — Cap-Rate Compression / Re-Rate | Cluster state Upside — NOI Growth / Cap-Rate Compression — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
4.64 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
4.64 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.15 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
144.3 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.04 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.99 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
- FY revenue ($B) < 1.25 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
- Probability-weighted fair value (PWEV) at the next re-run < 47.03 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $47.03; 52-week range $35.73–$51.01; engine rating HOLD; house target $49.21 (+5%). (source: Alpha Vantage 2026-09-08, 9 September 2026)
- INFERENCE: Triangulated FV $47.60 (+1% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
57.3/100 (confidence band 47.7–67.0), 47th percentile of 893 covered names (as of 2026-09-08). Weighted composite under config ros-1.20.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 51 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 19 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 55 | 15% | upside_pct |
| growth | 61 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 62 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 73 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 57 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | 76 | 10% | industry_context.house |
| risk profile | 66 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Score history: 56.8 → 57.1 → 57.9 → 57.3 → 57.6 → 57.5 → 57.7 → 57.4.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Rate Shock / Oversupply / Secular Decline | 20% | $25.02 | -46.8% | -9.4pp |
| Recession / Occupancy & SS-NOI Decline | 17% | $40.47 | -13.9% | -2.4pp |
| Base — FFO Growth + Stable Cap Rates | 35% | $51.75 | +10.0% | +3.5pp |
| Growth — Same-Store NOI + External Growth | 20% | $65.34 | +38.9% | +7.8pp |
| Bull — Cap-Rate Compression / Re-Rate | 8% | $76.85 | +63.4% | +5.1pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +4.6% |
| Expected return net of SBC dilution | +4.6% |
| Outcome dispersion (σ, from MC p10–p90) | 26.0% |
| Expected Sharpe (rf 4%) | 0.02 |
| Downside expectation (prob-weighted loss branches) | -11.7% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 4.6% |
| Risk-free rate | 4.12% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-09-03) |
| Beta (shrunk, 1y vs SPY) | 0.19 (as of 2026-09-08) |
| Equity risk premium | 4.5% |
| Required return | 5.0% |
| Expected alpha | -0.4% |
| Alpha per unit risk (EA/σ) | -0.01 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 33.3% (1σ) | 16.7% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 43.1% | the two expressions of our own view agree |
| Realised scenario frequency | 34 dated anchors | — | 34 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $49.21.
Factor Exposures
Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 93 | AI | 8 | |
| Value | 56 | Cloud | 3 | |
| Quality | 36 | Semis | 16 | |
| Momentum | 63 | Consumer | 7 | |
| Low-Vol | 52 | Rates | 36 | |
| USD | 82 | |||
| Energy | 52 |
Market interaction: correlation vs SPY +0.09, vs QQQ -0.00 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 66th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 54th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +10.7pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +10.7pp): 38-DTE 21% · 101-DTE 27% · 500-DTE 32%
| Priced structure | Value |
|---|---|
| Legs | Short 50 C |
| Expiry | 2026-10-16 |
| Income yield | 0.5% |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.52% NAV |
| Maximum position | 0.87% NAV |
| Risk budget | 1.36% NAV |
| Annualized outcome σ (MC) | 26.0% |
| Indicative holding period | 6–18 months |
| Liquidity | high, ~$78M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-09-08 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 21.0% (moderate regime) · expected move ±5.4% (2026-10-16) · put/call OI 0.80 · ATM Δ 0.54 / Θ -0.02 / ν 0.06 · next earnings 2026-10-29. Direction: NEUTRAL (implied return +1.2% to triangulated fair value $47.6).
Covered Call (if held) (Income / neutral) — Short 50 C · 2026-10-16 · premium $0.23 · yield 0.5% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 43 P / Long 40 P · 2026-10-16 · net $0.24 · net entry $42.76 · yield 0.6% · RoR 9.0% · max loss $2.76 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 42 P / Short 50 C · 2027-03-19 · net $0.52 · floor -11.0% · cap +6.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +5% vs spot
- Monte Carlo median implies -5% vs spot
- Bear case (Structural — Rate Shock / Oversupply / Secular Decline) downside is -47% vs spot
- Net: a reward leg exists but is negligible against the bear case — the reward-to-risk ratio would round to zero at display precision, and a displayed zero asserts a reward leg that is effectively absent — so the ratio is withheld as not asymmetric enough to print. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $1.2B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $1.3B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $1.9789 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.318B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $4.229B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.20.0 |
| Analysis as-of | 2026-09-09 (prices 2026-09-08) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 7/8 load-bearing inputs sourced; 11/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
No DCF anchor is meaningful for this asset; the blend leans 62% on probability-weighted scenarios and 37% on the Monte Carlo median — the scenario probabilities are the load-bearing inputs.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-09-08 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-09-08 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-09-08 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-09-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-09-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-09-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-09-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-09-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-09-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-09-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 11/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.